Contract Pharmaceutical Fermentation Services Market accounted USD 246.3 million in 2020 and will register to a CAGR of 4.8% during the forecast period. The fermentation process is nothing but the conversion of sugar into carbon dioxide and alcohol by the anaerobic method with the help of yeast.  In the pharmaceutical industry, fermentation process is employed for the preparation of various Active Pharmaceutical Ingredients (APIs). The fermentation was limited to various medically essential products such as antibiotics, solvents, citric acid and probiotics in this industry. Hence, the various type of product (anti-viral drugs, therapeutic recombinant proteins, monoclonal antibodies) and various types of antibiotics (antibacterial, antifungal, antiviral and anti-parasitic) are developed by implementing the fermentation technology. Therefore, fermentation remains a main process in the rapidly growing biopharmaceutical industry. The contract pharmaceutical fermentation services are mainly used by pharmaceutical industries when they need ample fermentation of products required for the development of drug and toll formulations utilizing different kinds of fermentation techniques with skilled staff. The extensive developments in biological products are used to curative solution for the cancer and other incurable diseases which turn to further propel the growth of this services market.

Market Segmentation:

Based on the product type, the global contract pharmaceutical fermentation services market is bifurcated into biotherapeutics, enzymes, peptides, plasmids, cytokines & growth factors, vaccines, and others. Based on platform, the market is classified into bacterial and fungal/yeast. On basis of service type, the market is categorised as development services and commercial services. Based on application, market is segmented into pharmaceutical, biotechnology, animal health, and others. By region, the contract pharmaceutical fermentation services market is segmented into North America (NA), Europe (EU), Asia Pacific (APAC), and RoW.

Market Dynamics and Factors:

Improving research and development in the pharmaceutical industry for developing product and biologics is one of the major drivers for the growth of the global contract pharmaceutical fermentation services market. Moreover, various new forms of drugs are being developed from active pharmaceutical ingredients, which are turn into increasing prevalence of diseases (cancer and diabetes) are some of the other factors which will drive the market. An expert of these services provider can upgrade the speed, quality, affordability and scalability of a pharmaceutical company's programme will also propel the demand in these markets. However, the high complexity of carrying out the fermentation procedure is responsible to restrain the market growth. Moreover, improved efficiencies for outsourcing processes across the value chain are creating immense opportunities for the market growth. Further, the large-scale fermentation create a threat to this market, the providers of contract pharmaceutical fermentation services are prompted to invest heavily in setting up their businesses and for recruiting technically-empowered staff are considered to be the challenge for contract pharmaceutical fermentation services market.

Geographic Analysis:

North America is expected to lead the highest growth of the global contract pharmaceutical fermentation services market, attributed to numerous pharmaceutical companies with R&D bases in this region. Europe is expected to be the second highest region due to high pharmaceutical industry supported by innovative product launch and favourable regulatory environment which is driven by UK, Spain, Italy, France and Germany.  Additionally, Asia pacific  are expected to fastest market for advancement in  pharmaceutical industry for developing product infrastructure and also continuous increasing demand from research organizations which further boosted  the contract pharmaceutical fermentation services market during the forecast period.

Competitive Scenario:

The key players of global contract pharmaceutical fermentation services markets are AbbVie, Inc., Aumgene Biosciences, Wisconsin BioProducts ,EKF Diagnostics – Stanbio, Boehringer Ingelheim International GmbH, Apotex Fermentation Inc., Biocon, Lonza, Corden Pharma International, and Fujifilm Holdings Corporation.

Contract Pharmaceutical Fermentation Services Market Report Scope